rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-7-22
|
pubmed:abstractText |
We have previously reported that a monoclonal antibody to CD45RB is a novel immunosuppressive agent; however, the optimal regimen in cardiac allografts remains unknown. The present study was undertaken to determine the optimal protocol of this therapy and its interaction with cyclosporine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1053-2498
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10363688-Animals,
pubmed-meshheading:10363688-Antibodies, Monoclonal,
pubmed-meshheading:10363688-Antigens, CD45,
pubmed-meshheading:10363688-Cyclosporine,
pubmed-meshheading:10363688-Disease Models, Animal,
pubmed-meshheading:10363688-Dose-Response Relationship, Drug,
pubmed-meshheading:10363688-Drug Interactions,
pubmed-meshheading:10363688-Drug Therapy, Combination,
pubmed-meshheading:10363688-Follow-Up Studies,
pubmed-meshheading:10363688-Graft Rejection,
pubmed-meshheading:10363688-Graft Survival,
pubmed-meshheading:10363688-Heart Transplantation,
pubmed-meshheading:10363688-Immunosuppressive Agents,
pubmed-meshheading:10363688-Male,
pubmed-meshheading:10363688-Mice,
pubmed-meshheading:10363688-Mice, Inbred BALB C,
pubmed-meshheading:10363688-Mice, Inbred C57BL,
pubmed-meshheading:10363688-Transplantation, Homologous,
pubmed-meshheading:10363688-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Cyclosporine inhibits long-term survival in cardiac allografts treated with monoclonal antibody against CD45RB.
|
pubmed:affiliation |
Department of Surgery, The University of Western Ontario, London, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|